XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity and Equity Incentive Plans
 9 Months Ended
Oct. 31, 2022
Stockholders' Equity Note [Abstract]  
Stockholders’ Equity and Equity Incentive Plans Stockholders’ Equity and Equity Incentive Plans
Common Stock
Our amended and restated certificate of incorporation authorizes the issuance of 2,000,000,000 shares of Class A common stock, $0.001 par value per share, and 300,000,000 shares of Class B common stock, $0.001 par value per share. Class A and Class B common stock are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted.
Stock Repurchase Plan
In February 2022, our Board of Directors authorized a stock repurchase program of up to $1.0 billion of our Class A common stock, which expires in February 2024. Repurchases of our Class A common stock may be effected from time to time, either on the open market (including preset trading plans), in privately negotiated transactions, and other transactions in accordance with applicable securities laws. The program does not obligate us to repurchase any specific number of shares and may be discontinued at any time.
During the three and nine months ended October 31, 2022, we repurchased and subsequently retired 6,955,529 and 11,044,500 shares of our Class A common stock, respectively, for an aggregate amount of $564.8 million and $990.8 million, respectively. As of October 31, 2022, $9.2 million of the repurchase authorization remained available.
Equity Incentive Plans
We have two equity incentive plans: the 2011 Global Share Plan (“2011 Plan”) and the 2019 Equity Incentive Plan (“2019 Plan”). All shares that remain available for future grants are under the 2019 Plan.
Stock Options
A summary of stock option activity under our equity incentive plan and related information is as follows:
 Stock Options
Outstanding
Stock
Options		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
(in thousands, except share, life, and per share data)
Balance as of January 31, 20226,195,205 $8.08 6.0$905,744 
Exercised(1,087,238)$6.27 $108,464 
Canceled/forfeited/expired(88,836)$21.49 
Outstanding as of October 31, 20225,019,131 $8.23 5.2$378,841 
Vested and expected to vest as of October 31, 20225,019,131 $8.23 5.2$378,841 
Exercisable as of October 31, 20224,861,214 $7.28 5.1$371,257 
As of October 31, 2022, unrecognized stock-based compensation expense related to outstanding unvested stock options was $3.5 million, which is expected to be recognized over a weighted-average period of 0.4 years.
Restricted Stock Units
A summary of restricted stock unit (“RSU”) activity under our equity incentive plan and related information is as follows:
RSUs
RSUsWeighted-
Average
Grant Date Fair Value Per Share
Unvested as of January 31, 20225,546,366 $232.58 
Granted17,750,637 $98.47 
Vested(2,865,551)$186.03 
Canceled/forfeited(1,392,277)$159.55 
Unvested as of October 31, 202219,039,175 $119.88 
In March and October 2022, changes made to our equity compensation program resulted in modifications of the value of RSUs offered to our employees. This activity has been included in our total Stock-Based Compensation disclosures below.
As of October 31, 2022, unrecognized stock-based compensation expense related to RSUs was $2,899.4 million, including the impact of the modification, which is expected to be recognized over a weighted-average period of 2.8 years.
2019 Employee Stock Purchase Plan
In April 2019, we adopted the 2019 Employee Stock Purchase Plan (“ESPP”). As of October 31, 2022, unrecognized stock-based compensation expense related to the ESPP was $66.5 million, which is expected to be recognized over a weighted-average period of 1.3 years.
Stock-Based Compensation
The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:
Three Months Ended October 31,Nine Months Ended October 31,
2022202120222021
(in thousands)
Cost of revenue$41,449 $17,206 $109,776 $46,050 
Research and development83,202 27,879 208,654 71,615 
Sales and marketing125,144 54,220 329,100 156,888 
General and administrative53,020 15,496 120,163 41,359 
Total stock-based compensation expense$302,815 $114,801 $767,693 $315,912 
Benefit from income taxes(53,995)— (151,027)— 
Total stock-based compensation expense recorded to net income$248,820 $114,801 $616,666 $315,912